These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18523263)

  • 1. T-bet plays a key role in NK-mediated control of melanoma metastatic disease.
    Werneck MB; Lugo-Villarino G; Hwang ES; Cantor H; Glimcher LH
    J Immunol; 2008 Jun; 180(12):8004-10. PubMed ID: 18523263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terminal NK cell maturation is controlled by concerted actions of T-bet and Zeb2 and is essential for melanoma rejection.
    van Helden MJ; Goossens S; Daussy C; Mathieu AL; Faure F; Marçais A; Vandamme N; Farla N; Mayol K; Viel S; Degouve S; Debien E; Seuntjens E; Conidi A; Chaix J; Mangeot P; de Bernard S; Buffat L; Haigh JJ; Huylebroeck D; Lambrecht BN; Berx G; Walzer T
    J Exp Med; 2015 Nov; 212(12):2015-25. PubMed ID: 26503444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KLRG1+ NK cells protect T-bet-deficient mice from pulmonary metastatic colorectal carcinoma.
    Malaisé M; Rovira J; Renner P; Eggenhofer E; Sabet-Baktach M; Lantow M; Lang SA; Koehl GE; Farkas SA; Loss M; Agha A; Campistol JM; Schlitt HJ; Geissler EK; Kroemer A
    J Immunol; 2014 Feb; 192(4):1954-61. PubMed ID: 24415778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cells inhibit T-bet-deficient, autoreactive Th17 cells.
    Wu W; Shi S; Ljunggren HG; Cava AL; Van Kaer L; Shi FD; Liu R
    Scand J Immunol; 2012 Dec; 76(6):559-66. PubMed ID: 22928727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD27low natural killer cells prolong allograft survival in mice by controlling alloreactive CD8+ T cells in a T-bet-dependent manner.
    Lantow M; Eggenhofer E; Sabet-Baktach M; Renner P; Rovira J; Koehl GE; Schlitt HJ; Geissler EK; Kroemer A
    Transplantation; 2015 Feb; 99(2):391-9. PubMed ID: 25606781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
    In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-bet and eomesodermin are required for T cell-mediated antitumor immune responses.
    Zhu Y; Ju S; Chen E; Dai S; Li C; Morel P; Liu L; Zhang X; Lu B
    J Immunol; 2010 Sep; 185(6):3174-83. PubMed ID: 20713880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo tumor suppression activity by T cell-specific T-bet restoration.
    Lee K; Min HJ; Jang EJ; Hong JH; Hwang ES
    Int J Cancer; 2010 Nov; 127(9):2129-37. PubMed ID: 20143391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular osteopontin regulates homeostasis and function of natural killer cells.
    Leavenworth JW; Verbinnen B; Wang Q; Shen E; Cantor H
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):494-9. PubMed ID: 25550515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosurveillance of lung melanoma metastasis in EBI-3-deficient mice mediated by CD8+ T cells.
    Sauer KA; Maxeiner JH; Karwot R; Scholtes P; Lehr HA; Birkenbach M; Blumberg RS; Finotto S
    J Immunol; 2008 Nov; 181(9):6148-57. PubMed ID: 18941205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.
    Lakshmikanth T; Burke S; Ali TH; Kimpfler S; Ursini F; Ruggeri L; Capanni M; Umansky V; Paschen A; Sucker A; Pende D; Groh V; Biassoni R; Höglund P; Kato M; Shibuya K; Schadendorf D; Anichini A; Ferrone S; Velardi A; Kärre K; Shibuya A; Carbone E; Colucci F
    J Clin Invest; 2009 May; 119(5):1251-63. PubMed ID: 19349689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse roles for T-bet in the effector responses required for resistance to infection.
    Harms Pritchard G; Hall AO; Christian DA; Wagage S; Fang Q; Muallem G; John B; Glatman Zaretsky A; Dunn WG; Perrigoue J; Reiner SL; Hunter CA
    J Immunol; 2015 Feb; 194(3):1131-40. PubMed ID: 25556247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F; Basse PH; Hokland M
    Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: immunity and IFN-gamma production during Listeria monocytogenes infection in the absence of T-bet.
    Way SS; Wilson CB
    J Immunol; 2004 Nov; 173(10):5918-22. PubMed ID: 15528324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocytes control natural killer cell differentiation to effector phenotypes.
    Soderquest K; Powell N; Luci C; van Rooijen N; Hidalgo A; Geissmann F; Walzer T; Lord GM; Martín-Fontecha A
    Blood; 2011 Apr; 117(17):4511-8. PubMed ID: 21389319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
    Hu HM; Winter H; Urba WJ; Fox BA
    J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SRC-3 Functions as a Coactivator of T-bet by Regulating the Maturation and Antitumor Activity of Natural Killer Cells.
    Hu M; Lu Y; Qi Y; Zhang Z; Wang S; Xu Y; Chen F; Tang Y; Chen S; Chen M; Du C; Shen M; Wang F; Su Y; Deng Y; Wang J
    Cancer Immunol Res; 2020 Sep; 8(9):1150-1162. PubMed ID: 32561537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma cells interfere with the interaction of dendritic cells with NK/LAK cells.
    Capobianco A; Rovere-Querini P; Rugarli C; Manfredi AA
    Int J Cancer; 2006 Dec; 119(12):2861-9. PubMed ID: 16998790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK and CD4 cells collaborate to protect against melanoma tumor formation in the brain.
    Prins RM; Vo DD; Khan-Farooqi H; Yang MY; Soto H; Economou JS; Liau LM; Ribas A
    J Immunol; 2006 Dec; 177(12):8448-55. PubMed ID: 17142742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.